Disseminated Neuroblastoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Disseminated Neuroblastoma trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06057948

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma…

United States94 participantsStarted 2023-09-21

Treatment: OPT-821 (QS-21), oral β-glucan

All recent trials (100 shown)

CompletedPhase 1

NCT00093353

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

RATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide, work in different ways to stop tumor cells from dividing so they stop growing or die…

United States30 participantsStarted 2004-05

Treatment: cefixime, irinotecan hydrochloride

AVAILABLENot Applicable

NCT01163383

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Metaiodobenzylguanidine (MIBG) is a substance that is taken up by neuroblastoma cells. MIBG is combined with radioactive iodine (131 I) in the laboratory to for…

United States

Treatment: 131 I-Metaiodobenzylguanidine (131 I-MIBG), 131 I-MIBG

Disseminated Neuroblastoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

All recent trials (100 shown)

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

All recent trials (100 shown)

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patie…

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastom…

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neu…

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor,…

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Soli…

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neu…

N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma

N99-02: Melphalan and Buthionine Sulfoximine

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for…

Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma